CardioGenics Holdings (CardioGenics Holdings) Accounts Payable & Accrued Expense : $1.47 Mil (As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Accounts Payable & Accrued Expense?

CardioGenics Holdings's quarterly accounts payable & accrued expense declined from Jul. 2015 ($1.09 Mil) to Oct. 2015 ($0.89 Mil) but then increased from Oct. 2015 ($0.89 Mil) to Jan. 2016 ($1.47 Mil).

CardioGenics Holdings's annual accounts payable & accrued expense stayed the same from Oct. 2013 ($0.83 Mil) to Oct. 2014 ($0.83 Mil) but then increased from Oct. 2014 ($0.83 Mil) to Oct. 2015 ($0.89 Mil).

CardioGenics Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for CardioGenics Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Accounts Payable & Accrued Expense Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.42

0.89

0.83

0.89

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.08	1.09	1.09	0.89	1.47

CardioGenics Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines